10
Mar

Zafgen’s in-development obesity treatment led to significant weight loss in patients with obesity triggered by a brain injury, meeting its goals and sending the biotech’s shares up nearly 8%.

…read more

Source: Zafgen’s obesity drug hits the mark in orphan disease trial

    

0 No comments